本页面由Tiger Trade Technology Pte. Ltd.提供服务

AIM ImmunoTech Inc.

0.1774
-0.0026-1.44%
盘前:0.1744-0.0030-1.69%04:52 EDT
成交量:48.28万
成交额:8.64万
市值:707.73万
市盈率:-0.05
高:0.1815
开:0.1800
低:0.1764
收:0.1800
52周最高:2.88
52周最低:0.1659
股本:3,989.48万
流通股本:3,789.62万
量比:0.74
换手率:1.27%
股息:- -
股息率:- -
每股收益(TTM):-3.9303
每股收益(LYR):-30.8884
净资产收益率:-2382.30%
总资产收益率:-82.58%
市净率:0.91
市盈率(LYR):-0.01

数据加载中...

2024/11/16

SEC问询函

Form CORRESP - Correspondence
2024/11/15

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/31

SEC问询函

Form CORRESP - Correspondence
2024/10/01

重要事件披露

Form 8-K - Current report
2024/09/12

重要事件披露

Form 8-K - Current report
2024/09/11

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/03

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/30

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/23

SEC问询函

Form CORRESP - Correspondence
2024/07/20

SEC问询函

Form CORRESP - Correspondence
2024/07/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/15

重要事件披露

Form 8-K - Current report
2024/07/12

SEC问询函

Form CORRESP - Correspondence
2024/07/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/07/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans